The effect of fish oil in patients with polycystic ovary syndrome

Phase 2

• Conditions: polycystic ovary syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20150606022562N4
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Women aged 18-35
Polycystic ovary syndrome on the basis of Rotterdam criteria
No smoking

Exclusion Criteria

Revealed diabetes
Hypothyroidism or hyperthyroidism
Hyperprolactinemia
Cushing's syndrome and adrenal and ovarian tumors
Unwillingness to continue cooperation
No regular use of the prescribed supplement

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total Testosterone. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: ELISA kit.;SHBG. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: ELISA kit.;Serum insulin. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: Calculated with suggested formula.;Insulin sensitivity. Timepoint: At the beginning of the study and 12 weeks after intervention. Method of measurement: Calculated with suggested formula.